Kommentar zu HERZ THORAX – Parametrische Kardio-MRT bewährt sich in Real-World-Szenario

Rofo 2023; 195(06): 476-477
DOI: 10.1055/a-2038-2837

Brennpunkt

Authors

Tilman Emrich

¹Klinik und Poliklinik für Diagnostische und Interventionelle Radiologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

Literatur
1 Leiner T, Bogaert J, Friedrich MG. et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2020; 22: 76
2 Puntmann VO, Peker E, Chandrashekhar Y. et al. T1 Mapping in Characterizing Myocardial Disease. Circ Res 2016; 119: 277 LP-299
3 Warnica W, Al-Arnawoot A, Stanimirovic A. et al. Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy. Radiology 2022; 305: 319-326
4 Reiter G, Reiter C, Kräuter C. et al. Cardiac magnetic resonance T1 mapping. Part 1: Aspects of acquisition and evaluation. Eur J Radiol 2018; 109: 223-234
5 Emrich T, Hahn F, Fleischmann D. et al. T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction. ESC Hear Fail 2020; 7: 2544-2552